Introduction
Cancer control is a health priority. Cancer is estimated to be the leading cause of burden of disease in Australia in 2010, accounting for 19% of the total burden, and has a major impact on the Australian community, since one in three men and one in four women in Australia will be diagnosed with cancer by the age of 75. By age 85, the risk increases to one in two for men and one in three for women (Cancer Council Australia, 2012) . The proportion of elderly people in the population will steadily increase over the next decades due to increased life expectancy (ROTC, 2012a ) and the 'baby boomers' ageing population is entering the high incidence period, thereby increasing the number of cancer cases.
Beyond demographic influences, other factors like socio-economic status and ethnicity have also an effect on cancer incidence (ROTC, 2012a) along with geographical variations in the rate of treatment and survival from cancer (Coory et al., 2013; Yu et al., 2014) . As the number and diversity of cancer cases increase, the pressure on specialised treatment services will increase, calling for better planning and allocation of healthcare resources, particularly at the regional level.
Radiotherapy (RT) is an essential cancer therapy whether aimed at cure or palliation. The Collaboration for Cancer Outcomes Research and Evaluation (CCORE) literature-based findings were used by the Radiation Oncology Reform Implementation Committee (RORIC) to estimate that 52.3% of all diagnosed cancer cases in Australia would benefit from radiotherapy at some point after diagnosis. The Australian state health department uses this estimate for planning their RT services (Delaney et al., 2003; ROTC 2012b; Morgan 1999) .
Radiotherapy is considered to be most cost effective than surgery and chemotherapy, when all costs across the life cycle is considered (Ploquin and Dunscombe 2008) . According to the RANZCR, radiotherapy provides similar benefit with lower costs for cancer patient treatment for cures. RT generally costs about 6 per cent of each health dollar spent fighting cancer, but it is a vital part of curing about 40 per cent of all cured cancers. As radiation therapy is provided as an outpatient treatment service, the overall treatment costs are less than other treatments. In terms of effectiveness, an Australian study stated that external-beam radiation therapy is at least as effective as modern Australian surgical techniques (Wilcox et al. 2015) .
It states that men with localised prostate cancer (≈30.0% of all new cancers in men) who are treated with external-beam radiation therapy have a cure rate of 95.5% for intermediate-risk prostate cancer and 91.3% for high-risk prostate cancer. Also, for breast cancer (≈28% of all new cancers in women) treatment studies conducted in Canada and Denmark, have shown a 9%-10% improvement in overall survival at 10 years for patients that received radiotherapy compared with patients who did not receive radiotherapy (Vinh-Hung and Verschraegen 2004, Ragaz et al. 1997) . Like these there are other studies which show better outcomes and cost-effectiveness for RT treatments for different types of cancer and their stages. However, measured access to RT services has established that utilization rates are well below this optimal number (Mackillop et al., 1997; Barton 2000; Einhorn et al. 1996; Athas et al., 2000) clearly demonstrating the existence of barriers to access existing RT services.
Currently, only 38% of cancer sufferers receive radiotherapy during their disease journey (ROTC 2012a, Barton and Delaney 2011; indicating that ~14% of cancer sufferers, miss the benefit from RT services that may improved cancer control and appropriate evidence-based management (ROTC 2012a, Barton and Delaney 2011) . Since the proximity of RT facilities to home has been identified as a major factor enhancing accessibility to and utilization of RT services (Mackillop et al., 1997; , it is likely that remote and rural patients are facing limited accessibility to radiotherapy on the basis of inadequate transportation and lengthy travel. A literature review has highlighted travel as a perceived barrier to cancer treatment (Payne et al., 2000) . Several national and international studies supported the relation between travel distance from radiotherapy centres and uptake rates (The Allen Consulting Group, 2012; Williams 2009; Cancer Care Ontario, 2008; Schroen et al. 2005; Craft et al., 2010; Badde et al., 2011; Wigg and Morgan, 2001; Morgan et al., 2010) . Although the configuration of centralised networks may be driven by resource efficiency savings, it has reflecting clinical need in rural and remote areas will appear less resource efficient (Asthana et al 2003) .
Various studies have examined the effect of geographical accessibility, based on travel times/distances as proxy to travel effort, on uptake of RT based cancer treatment. For example, Madelaine et al. (2002) reported lower treatment rates for rural lung cancer patients in France. Punglia et al. (2006) found that increasing distance to the nearest radiotherapy centre was associated with a decreasing likelihood of receiving post-mastectomy radiation therapy. Greenberg et al., (1988) asserted that lung cancer patients living at greater straight line distance from a specialist cancer centre, in rural USA, were significantly more likely to undergo surgery but were less likely to receive radiotherapy or chemotherapy than closer patients. Athas et al. (2000) also found that breast cancer patients living further than 75 miles from a radiotherapy services centre were significantly less likely to receive radiotherapy than those living closer. It is possible that the detriment of transportation may be even more pronounced in patients who are faced with weeks of daily outpatient treatment, as is common for radiation therapy. Some recent studies have reported the location assessment for public healthcare facilities in US. Batta et al. (2014) has used p-maxian model considering dispersion, population, and equity for obtaining the optimal locations of public facilities.
Another study by Burkey et al. (2012) has used location-based comparisons based on efficiency and equity to compare healthcare services in four US states. Our paper will use some of these indices (general efficiency, service availability and distance-based equity) to evaluate the potential RT service locations.
Recently, Gabriel et al. (2012) presented the results from the data linkage study for radiotherapy utilisation rates in NSW and Australian Capital Territory (ACT) for years 2004-06. They concluded that the radiotherapy utilisation rates decreased with increasing distance from patient's residence to the nearest RT facility (p<0.0001). The study quantified RT rates ranging from 27% for patient living within 50 km of RT facility to 19% for patients living more than 400 km from the nearest RT facility. Recently, various studies ; ; Tyagi et al. (2015) ) have only focussed on within organisation (or hospital) level process improvements but have not considered patient accessibility measures for improvements.
The planning of efficient and accessible RT services for cancer care at regional level requires estimates of current and future cancer demand based on the spatial distribution and evolution of various socio-demographic groups, spatial accessibility based on transport network and probabilities of re-treatment. In this study, we will develop a modelling tool which can be systematically used for planning of radiotherapy services.
After detailing the data and methods used in the modelling effort, we will demonstrate how we have applied these modelling methods to plan and evaluate RT services in NSW.
Approach for planning of radiotherapy services
The proposed approach for modelling and predicting the future cancer incidences and their accessibility to existing RT centres in the state is visualised in Figure 1 , and involves datasets such as Australian Institute of Health and Welfare (AIHW) cancer incidence data, Australian Bureau of Statistics (ABS) population projection dataset, 1km Australian population grid dataset, road network dataset, and data about the existing radiotherapy (RT) centres.
Datasets used in the proposed approach
A. AIHW cancer incidence dataset The AIHW cancer incidence dataset (AIHW, 2014) provides the information about age group and sex specific cancer rates for all and specific cancer types in Australia. The major source of this data comes from the Australian Cancer Database (ACD) which contains records of all the primary, malignant cancers (except basal cell and squamous cell carcinomas of the skin) diagnosed in Australia since 1982. The data from ACD is generally used to report national cancer statistics such as incidence, trends, projections, survival, and prevalence. The ACD data is compiled from the data provided by the state and territory cancer registries through Australasian Association of Cancer Registries (AACR). The age-specific rates (ASR) for cancer in males and females, in past years, are used to model and predict the cancer incidences in the state.
B. ABS population projection dataset
The population projection data prepared by the ABS to permit the Australian Government Department of Social Services to plan and evaluate aged care. These projections are based on the past trends (over a decade) of fertility, mortality, and migration trends, using the cohortcomponent method, where the base population is projected into the future year annually by estimating the effect of births, deaths and migration within each age-sex group according to the specified fertility, mortality and migration assumptions. This datasets contains the age 
D. Road network dataset
The road network dataset was downloaded from the most up-to-date OpenStreetMap (OSM) database, using Quantum GIS software (Gray, 2008) . OpenStreetMap is a crowd-sourced initiative to collect and map roads, trails, and points of interest, with an ultimate aim of building a geographic database that contains every single feature on the planet (Bennett, 2010) . OSM data was selected for this study as it is a readily available and open data source with sufficient positional accuracy (Haklay, 2010 ).
E. Existing radiotherapy (RT) centres
The data about the existing RT treatment facilities is accessed from Department of Health, Australia. DoH (2014) provides publically available information about radiation therapy services including accommodation and travel schemes, facility locations and treatment options. The facility locations for RT centres were used for estimating the RT treatment accessible regions for future cancer incidences.
Methods
A. Age specific rate (ASR) for cancer incidence modelling A non-linear polynomial regression model (of degree 3) was used to model the past trend of the cancer incidences. The polynomial regression models have been developed for each agesex group for male and female. Age specific rates (ASR) from AIHW dataset, for cancer incidences for years 1982 to 2009, have been used to estimate the coefficients of the regression model. The model used for ASR regression is:
Where, is the age-specific rate for a particular age-sex group observed in year . is assumed to be independent and identically distributed normal random variable with mean zero and a constant variance.
The AIHW cancer incidence dataset for years 1982-2009 is used for estimating coefficients 0 -3 . The confidence level is set to be 95% for the two sided hypothesis test. If the ASR model for an age-sex model is found significant, then is estimated based on Eq. (1).
Otherwise, mean of (where, = 2000,2001, … ,2009) for recent 10 years for a particular age-sex group is used for prediction. In this modelling, we have made following assumptions:
i. this modelling assumes that the incidence is homogeneous across different local government areas (LGAs) ii. ages were grouped in 5 year interval for this modelling and it assumes that each age group is homogeneous
iii. it is assumed that the past trends in cancer incidences will continue in future B. Predicting the cancer cases
Once the regression models for the cancer incidence is obtained for each age-sex group, it is then used together with the ABS population projections dataset to estimate the future cancer cases in the study area. The ABS population dataset is aggregated into a contingency (Douglas and Douglas, 2005) . We were mainly interested in the function 'pgr_drivingDistance' to calculate driving distance polygons (pgRouting Contributors, 2013) . This function computes the cost (distance) to reach every node in the network from a given starting node based on a Dijkstra shortest path solution.
Further details of the Dijkstra algorithm and its applications to road networks can be found in Zhan and Noon (1998) .
Firstly, the OSM road network of NSW was imported into PostgreSQL/PostGIS as a pgRouting-enabled (i.e. routable) network dataset. A custom SQL function that leverages the default pgRouting function 'pgr_drivingDistance' was written to loop through all treatment centres. This custom function takes each treatment centre as the starting node, and computes all nodes in the road network that can be reached within a specified threshold distance. The concave polygon that encompasses the collection of nodes computed above was then generated using a standard function available in PostGIS. This concave polygon is termed the 'constant driving distance polygon' or isochrone.
Considering the fact that dwellings are not uniformly distributed in space, the digital dataset of the population grid was used to estimate the fraction of the population that lives in a particular LGA within a given distance ring.
Let , be the portion of population of the i th LGA that lives within the j th distance ring, and be the total population of the i th LGA, then the fraction of population (of i th LGA) in j th distance ring (denoted by , ) is given by:
under the condition ∑ , =1 for each LGA.
D. Radiotherapy based treatment demand estimation
The predicted cancer cases and distance-based LGA ratios ( , ) were used together with the radiotherapy rates to estimate the future demand for RT services. The RT rates were chosen based on the distance bands provided in Gabriel et al. (2012) . They calculated the actual radiotherapy treatment rates for cancer patients in NSW & ACT (2004-06) from patient treatment records to estimate the effects of geographic variations on the RT rates. The road distance between patient residence and the nearest RT centre was estimated to compute the rates of radiotherapy for patients living <50Km, , and 400+ Km. The dataset used for this study was from [2004] [2005] [2006] . Since this dataset is nearly 10 years old, we have added another data source, i.e., local health district cancer treatment data containing radiotherapy data for years 2006 -2012. This local health district is out of the eight in NSW. Using both of these datasets we have estimated the average radiotherapy rates for cancer patients based on their driving distances to the nearest RT facilities. The combined average rates for RT are presented in Table 1 . Evidence for radiotherapy based treatments such as systematic review of relevant randomised studies, randomised/controlled trials, and case series, were used in modelling decision trees for determining optimal radiotherapy rates. For more information about these rates and methodology see Delaney (2007) . The optimal RT rates varied from 0% in case of liver cancer patients and 92% for patient with central nervous system tumors. The optimal radiotherapy utilisation rate was estimated to be 52.3% of all the notifiable cancer in Australia. The SSDB (2012) report indicates that an additional 23% of the cancer patients receive at least 2 course of RT (retreatment). Some retreatments are for second cancer and other for metastatic events. We have used the estimated rate of 52.3% for determining the optimal RT demand for the future year.
Evaluation of new radiotherapy centres based on efficiency, service availability and equity
We have used the proposed modelling work to estimate the change in patient access with the opening of new RT centre. We have employed three measures to quantitatively assess/evaluate the locations of new RT centres -general efficiency, service availability and equity. These measures have been used previously to evaluate locations of healthcare facilities (Batta et al. 2014 , Burkey et al. 2012 .
A. General efficiency: for general efficiency, we have considered the average distance between any potential cancer patient and his closest RT facility. In literature, various researchers have used such measures for evaluating facility location problems in healthcare. Batta et al. (2014) have used dispersion and population criteria as the proxies for measures of general efficiency. They focussed on minimising the cost of providing the service. We are using this measure as a proxy for general efficiency for RT service provision.
B. Service availability:
The proxy for service availability is defined to be the population coverage for RT treatments. Specifically, the coverage can be measured as the proportion of the potential cancer patients that is located within a pre-specified distance from their closest RT facility. This measure of coverage was first defined by Toregas et al. (1971) . According to this measure, a cancer patient is considered covered if he is living no farther than 50KMs from the closest facility. The union of coverage areas for each RT centre is then represents service availability. We are considering 50 KM as the coverage driving distance because previous research studies (Gabriel et al. 2012 ) and our analysis of cancer treatment records indicated that patients living less than 50 Kms from the closest RT facility were receiving highest rates of radiotherapy based treatments. Radiotherapy is considered a necessary component of treatment in 52% of all newly diagnosed cancers .
Radiotherapy is considered to be most cost effective than surgery and chemotherapy, when all costs across the life cycle is considered (Ploquin and Dunscombe 2008) .
C. Equity: the equity measure helps to quantify aspects related to fairness, justice of the service provision, and neediness. Burkey et al. (2012) have used a measure known as Gini index, which is based on Lorenz curve in economics. These curves are used as a graphical illustration of inequality for any quantitative study where inequality is measured. Gini index is a scalar measure based on Lorenz curve to quantify inequality (Gini 1921 ). Gini index is always between 0 (indicating total equality) and 1 (indicating total inequality). We have used this measure for determining the equality for potential cancer patients to access RT based treatment.
All of these measures are used to evaluate the alternative locations of new RT centres. Interested parties can access the software tools developed in this study freely by contacting authors.
Results and Discussion
This study estimates a spatially explicit demand and accessibility for radiotherapy services in the NSW state of Australia using methods described above. The choice of the NSW was justified by the accurate data currently available for NSW and a well-defined geographical area that is known to mirror average demographic distributions in Australia. Figure 2 illustrates population grid (1Km 2 ) distributed in the whole of NSW state and existing locations of RT centres in NSW.
Non-linear regression for each age-sex group were conducted on the past cancer incidence data from AIHW. In both males and females, a statistically significant time trend was found for the following groups (α<.05): '40-44 yrs ', '45-49 yrs', '50-54 yrs', '55-59 yrs', '60-64 yrs ', '65-69 yrs', '70-74 yrs', '75-79 yrs', '80-84 yrs', and '85+ yrs' . Figure 3 illustrates the results from non-linear regression analysis (all age groups combined) of cancer incidences projected in future and its comparison with the past incidence rates. In Figure 3 , the overall rates for cancer incidence in females are not increasing compared to the incidences in males.
The dotted lines in Figure 3 The NSW population data provided by the ABS was used in this study. Figure 4 illustrates the growth in overall population of NSW from 2011 to 2026. It is evident that the population will grow significantly in future. However, the growth in population in different age groups and sex varies across NSW. In year 2026, number of individuals in age groups with a higher cancer incidence (i.e., above 50 years) will be larger than 2011 for both females and males (see Figure 5 ). There will be more aged people living in year 2026 in NSW, and because of cancer incidence in the aged population sub-groups, more cancer cases. This was done to account for patient leakage in to those centres from NSW. As described in Section 2.2.C, for each LGA the fraction of population living in each distance band is estimated. Table 2 shows these calculated fractions for two LGAs as an example. The distance-based LGA ratios ( , ) in the NSW (illustrated in Table 2 ) were used together with the cancer cases for respective LGA (illustrated in Figure 6 ) to estimate the total number of cancer patients residing in each distance band. The cancer cases residing in each distance band can be used for planning and locating new radiotherapy centres. The proposed approach was then applied to estimate change in access of cancer patients with the opening of new radiotherapy centre in Shoalhaven LGA (see Figure 3) . We have run the travel distance modelling method for the scenarios before and after opening of new RT centre. The change in cancer patient's access for before and after opening of RT centre is presented in Figure 8 . It can be seen that there are more than 600 cancer cases residing in the 50 km road distance from the nearest RT centre when the new RT centre is operational. The number of RT cases residing within 50km of nearest RT centre in the Illawarra and Shoalhaven local health district before and after is 1120 and 1511. Interestingly, within 6 months of opening the Shoalhaven RT service is already managing 500 new RT cases per month (A.Miller, personal communication) . Due to the opening of new centre, there are less cancer cases living in distance bands (in km) 50-99, 100-149, 150-199, 200-249 , therefore the difference between the numbers of cancer cases is negative. For larger distance bands (250-299, 300-349, 350-399, 400+) , the number of cancer cases are constant for before and after RT centre placement. Table 4 should be minimised. Table 5 illustrates the demand for the RT services based on the radiotherapy rates estimated in Section 2.2.D. RT demand at the current service level is calculated by applying RT rates by road distance (estimated in Table 1 ) to the number of cancer patients living in each distance bands (see Section 2.2.B and 2.2.C). However, the optimal RT demand is estimated by using cancer incidence number and optimal RT utilisation rates (52.3%, see Section 2.2.D). It can be concluded from Table 5 that supply of RT services significantly lags behind the evidence-based optimal demand and new RT centres should be established to deal with such shortfall. This trend of shortfall will continue in future at the current service levels. The proposed approach offers an innovative way to assess/evaluate the alternative locations of new RT services based on -general efficiency, service availability, and equality.
Conclusion
The treatment of cancer, which touches a large proportion of the community, represents a significant health and economic burden in Australia. Nearly one in two men and one in three women have a lifetime risk of being diagnosed with cancer in NSW. Radiotherapy (RT) based cancer treatments are often integral to achieving permanent or long-term remission.
There will be large demand for RT services for cancer patients in NSW in next ten years.
However, decision on new linear accelerator (LINAC) units take time, resulting in local congestion of services or unreasonable travel time for patients, with some individuals opting out of RT treatment reducing demand but not the need. Thus, there is pressing need to rationally justify the placement of new radiotherapy centres to effectively meet the future RT need of future cancer patients. This study makes a unique contribution to the policy debate on placement of RT treatment centres through the establishment of an integrated modelling approach. This study marks an attempt at informing the government about the best placement locations for RT centres to maximise the RT service capacity to meet future cancer patient demand.
The demonstrated generic approach includes cancer incidence predictive modelling to estimate the cancer cases residing within different travel distance bands from the RT centres, and is easily applied to the NSW circumstance. The methods described in this research study can be applied in other jurisdictions with availability of the necessary data.
We are aware of limitations in our current approach which are being addressed with more research. We have assumed that the OSM road network data is complete. As the OSM data becomes more complete in time, we only need to reimport that dataset to update the analysis.
In estimating future cancer cases, we assume that the residential locations remain the same, but including research on dynamic land use modelling is expected to better account for residential area growth. The cancer incidence modelling assumes the same incidence across different local government areas (LGAs) and that the past trends will continue in future.
Lastly, the model can be refined to include detailed information about the individual cancer incidences, radiotherapy demand, and accessibility profiles rather than using all inclusive assessments. In current study, authors are dealing with all types of cancer and their aggregated rates; therefore, survival analysis is not conducted for different types of cancer cases and their stages. We hope this type of analysis can be conducted in future based on our work.
